| SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer | |
| Han, Fei; Liu, Wen-bin; Li, Jian-jun; Zhang, Ming-qian; Yang, Jun-tang; Zhang, Xi; Hao, Xiang-lin; Yin, Li; Mao, Cheng-yi; Jiang, Xiao | |
| 刊名 | ENDOCRINE-RELATED CANCER
 |
| 2019 | |
| 卷号 | 26期号:3 |
| 关键词 | prognostic factor chemotherapy tumor metastasis epithelial-mesenchymal transition transcriptional regulation ovarian cancer |
| ISSN号 | 1351-0088 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3412939 |
| 专题 | 昆明医科大学 |
| 推荐引用方式 GB/T 7714 | Han, Fei,Liu, Wen-bin,Li, Jian-jun,et al. SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer[J]. ENDOCRINE-RELATED CANCER,2019,26(3). |
| APA | Han, Fei.,Liu, Wen-bin.,Li, Jian-jun.,Zhang, Ming-qian.,Yang, Jun-tang.,...&Liu, Jin-yi.(2019).SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer.ENDOCRINE-RELATED CANCER,26(3). |
| MLA | Han, Fei,et al."SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer".ENDOCRINE-RELATED CANCER 26.3(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论